DexamethasoneBone marrow necrosis following off label treatment with dexamethasone: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1902卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13311-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[1] Dexamethasone/piperacillin/tazobactamNeurocandidiasis following off label use: case report
Reactions Weekly, 2022, 1928 (1) : 155 - 155
[2] Dexamethasone/tocilizumabPulmonary cryptococcosis following off label use: case report
Reactions Weekly, 2023, 1980 (1) : 145 - 145
[3] GlibenclamideHypoglycaemia following an off label treatment: case report
Reactions Weekly, 2018, 1708 (1) : 161 - 161
[4] OxaliplatinFever following off label treatment: case report
Reactions Weekly, 2022, 1898 (1) : 317 - 317
[5] Dexamethasone/pembrolizumabTumour progression following interaction between pembrolizumab and an off label dexamethasone: case report
Reactions Weekly, 2022, 1926 (1) : 205 - 205
[6] DexamethasoneEntamoeba histolytica -associated colitis and liver abscesses following off label treatment with dexamethasone: case report
Reactions Weekly, 2023, 1938 (1) : 500 - 500
[7] Dexamethasone/tocilizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1968 (1) : 122 - 122
[8] Dexamethasone/sarilumabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1963 (1) : 213 - 213
[9] Bortezomib/dexamethasone/venetoclaxSepsis following off-label treatment for relapsed/refractory amyloidosis: case report
Reactions Weekly, 2021, 1844 (1) : 100 - 100
[10] Ceftriaxone/dexamethasone/spiramycinLack of efficacy following off label use: case report
Reactions Weekly, 2022, 1935 (1) : 137 - 137

← 1 2 3 4 5 →